Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.
Roubey
R A
RA
Division of Rheumatology and Immunology, Thurston Arthritis Research Center, University of North Carolina at Chapel Hill.
D017153:Antibodies, Anticardiolipin / Q000276:immunology*; D017152:Antibodies, Antiphospholipid / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D001792:Blood Platelets / Q000502:physiology; D011464:Epoprostenol / Q000096:biosynthesis; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology*; D015539:Platelet Activation; D011486:Protein C / Q000276:immunology; D017293:Protein S / Q000276:immunology; D013917:Thrombin / Q000276:immunology; D013925:Thromboplastin / Q000378:metabolism; D013927:Thrombosis / Q000503:physiopathology; D053482:beta 2-Glycoprotein I
D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D001323:Autoantibodies; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D011486:Protein C; D017293:Protein S; D053482:beta 2-Glycoprotein I; D013925:Thromboplastin; D011464:Epoprostenol; D013917:Thrombin